Showing results (101-110 of 162) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancerJ Michael Dixon, Lorna Renshaw, Oliver Young, et al.Exploration of Targeted Anti-Tumor Therapy|April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer modelKate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.BMC Cancer|April 7, 2018
Adjuvant trastuzumab duration trials in HER2 positive breast cancer - what results would be practice-changing? Persephone investigator questionnaire prior to primary endpoint resultsLouise Hiller, Janet A Dunn, Shrushma Loi, et al.Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.Breast Cancer Research and Treatment|June 4, 2011
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancerMelanie Spears, Karen J Taylor, Alison F Munro, et al.British Journal of Cancer|June 20, 2020
Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry dataInes Mesa-Eguiagaray, Sarah H Wild, Philip S Rosenberg, et al.International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-upIan H Kunkler, Gillian R Kerr, Jeremy S Thomas, et al.The Oncologist|May 17, 2011
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancerDavid Miles, Henri Roché, Miguel Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancerLuca Gianni, Anna Lladó, Giulia Bianchi, et al.Breast Cancer Research : BCR|June 24, 2010
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancerKaren J Taylor, Andrew H Sims, Liang Liang, et al.Pageof 17